CUAMC
VNDA icon

China Universal Asset Management Company’s Vanda Pharmaceuticals VNDA Stock Holding History

China Universal Asset Management Company’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.6K Sell
9,571
-918
-9% -$6K ﹤0.01% 453
2026
Q1 		$72.5K Buy
10,489
+859
+9% +$6.62K 0.01% 435
2025
Q4 		$84.9K Sell
9,630
-727
-7% -$4K 0.01% 417
2025
Q3 		$51.7K Sell
10,357
-1,480
-13% -$6.85K ﹤0.01% 430
2025
Q2 		$55.9K Buy
11,837
+140
+1% +$612 0.01% 411
2025
Q1 		$53.7K Sell
11,697
-666
-5% -$3.1K 0.01% 415
2024
Q4 		$59.2K Buy
12,363
+1,152
+10% +$5.53K 0.01% 442
2024
Q3 		$52.6K Buy
11,211
+4,374
+64% +$23.4K 0.01% 384
2024
Q2 		$38.6K Sell
6,837
-4,208
-38% -$21.7K 0.01% 373
2024
Q1 		$45.4K Buy
11,045
+4,387
+66% +$17.6K 0.01% 416
2023
Q4 		$28.1K Buy
6,658
+5,186
+352% +$20.9K 0.01% 403
2023
Q3 		$6.36K Buy
1,472
+719
+95% +$4K ﹤0.01% 376
2023
Q2 		$4.96K Sell
753
-16
-2% -$103 ﹤0.01% 368
2023
Q1 		$5.22K Buy
769
+194
+34% +$1.36K ﹤0.01% 361
2022
Q4 		$4.25K Buy
575
+45
+8% +$438 ﹤0.01% 314
2022
Q3 		$5K Buy
+530
New +$5.6K ﹤0.01% 278

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

China Universal Asset Management Company's VNDA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Vanda Pharmaceuticals (VNDA) stake by 8.8% in Q2 2026, selling an estimated $6K and leaving 9,571 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

China Universal Asset Management Company first reported a position in VNDA in Q3 2022 and has held it in 16 quarters since. The position peaked at $84.9K in Q4 2025. 88 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • China Universal Asset Management Company held 9,571 shares of Vanda Pharmaceuticals worth $58.6K as of Q2 2026.
  • China Universal Asset Management Company sold 918 Vanda Pharmaceuticals shares in Q2 2026, an estimated $6K.
  • Vanda Pharmaceuticals made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #453 holding.
  • China Universal Asset Management Company first reported a position in Vanda Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Vanda Pharmaceuticals position peaked at $84.9K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.